 NEW YORK, Sept. 14, 2022 GLOBE NEWSWIRE -- Axsome Therapeutics, Inc. NASDAQ: AXSM, a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system CNS disorders, today announced that Herriot Tabuteau, MD, Axsomes Chief Executive Officer, will participate in a virtual fireside chat at the Cowen 2nd Annual Novel Mechanisms in Neuropsychiatry Summit on Monday, September 19, 2022 at 12:05 PM Eastern Time. 